L’Oréal has finalized the acquisition of Lactobio, a Copenhagen-based cosmetics company specializing in the study of “living bacteria”. This move enables the cosmetics giant to enter the fast-growing market for skincare products using probiotic ingredients.
On December 4, L’Oréal announced the acquisition of Lactobio, a cosmetics biotech company specializing in the study of “living bacteria”. The amount of the transaction was not disclosed.
Founded in 2017 in Copenhagen, Lactobio is a Danish skincare company based on probiotic and post-biotic formulations operating under private label. It claims to be able to “select the most effective and safest strains”. At the same time, the biotech company manages its own probiotic skincare brand, Bak.
With this external growth operation, the l’Oréal group is strengthening its research division on the microbiome (micro-organisms present in the human body, particularly on the skin, and playing a decisive role in health and disease, editor’s note).
The acquisition of Lactobio “consolidates 20 years of advanced research on the microbiome“, the press release states, and enables the world’s leading beauty company “to deepen its knowledge of living micro-organisms on the skin’s surface and strengthen its leadership in this field”.
Create your free account I create my account Don’t miss out on the latest luxury business news.
To continue reading this article, create a free account or log in.
Read also > DESPITE THE SLOWDOWN IN CHINA, L’ORÉAL IS PERFORMING WELL IN THE THIRD QUARTER
Featured Photo: © L’Oréal
